United StatesSemaglutide‑Glycine‑Cyanocobalamin Injectable (2.5 mg, 5 mg; 1 mg/mL; 0.5 mL vials), prescription only, compounded by Payless Compounders/Northwest Compounders in Beaverton, Oregon, lot number 01-27-2026@14S.5, sold in Oregon is affected. It was recalled because there is a lack of assurance of sterility.
What's being recalled
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Recalling firm: Payless Compounders, LLC, Beaverton, OR, United States.
How to identify it
Lot Number 01-27-2026@14S.5
The hazard
Lack of Assurance of Sterility
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
OR
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)